Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Antigen Presenting Cells01:22

Antigen Presenting Cells

3.7K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-2 Free Expansion of T Cells with Immunofilaments.

Advanced healthcare materials·2026
Same author

Biomolecule Conjugation Strategy for HAGM Cryogels to Create 3D Immune Niches that Induce Multifunctional T Cells.

ACS biomaterials science & engineering·2025
Same author

Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responses.

RSC chemical biology·2025
Same author

Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Nature biomedical engineering·2025
Same author

ImmuNet: a segmentation-free machine learning pipeline for immune landscape phenotyping in tumors by multiplex imaging.

Biology methods & protocols·2025
Same author

Assessment of scattered and leakage radiation from ultra-portable X-ray systems in chest imaging: An independent study.

PLOS global public health·2025

Related Experiment Video

Updated: Apr 27, 2026

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

7.2K

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.

Loek J Eggermont1, Leonie E Paulis1, Jurjen Tel1

  • 1Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Trends in Biotechnology
|July 8, 2014
PubMed
Summary

Artificial antigen-presenting cells (aAPCs) offer a promising alternative to natural APCs for cancer immunotherapy. Optimized aAPCs with tunable properties may enhance immune responses and improve clinical outcomes.

Keywords:
artificial antigen-presenting cellcancerimmunotherapysynthetic dendritic cell

More Related Videos

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

17.1K
Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

9.5K

Related Experiment Videos

Last Updated: Apr 27, 2026

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

7.2K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

17.1K
Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

9.5K

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Effective anti-cancer immunity relies on antigen-presenting cells (APCs) presenting tumor antigens and co-stimulatory signals.
  • Current autologous natural APC therapies are expensive, time-consuming, and yield variable clinical results.

Purpose of the Study:

  • To explore the characteristics and clinical potential of acellular artificial APCs (aAPCs) in cancer immunotherapy.
  • To review how aAPC properties influence T cell activation and therapeutic efficacy.

Main Methods:

  • Discussion of various acellular aAPC types.
  • Analysis of how aAPC physical characteristics (size, shape, ligand mobility) and signal presentation impact T cell responses.

Main Results:

  • Acellular aAPCs present a viable alternative to natural APCs for cancer immunotherapy.
  • aAPC properties significantly affect cytotoxic T cell activation.

Conclusions:

  • Optimized aAPCs with precisely tuned properties hold potential for efficient immunomodulation.
  • Novel aAPC designs may lead to improved clinical responses in cancer immunotherapy.